OQROGet OQRO Pro
Insider trade

Roivant Sciences (ROIV)Director sold ~$17.1M

Mayukh Sukhatme, Director at Roivant Sciences, sold ~$17.1M of Roivant Sciences shares.

~$17.1M
Approx. value · 500K sh @ $34.13
18.7M
Holds after · shares reported
Traded
Jun 25, 2026
Filed
Jun 30, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. May 20, 2026Company filing · Form 8-K · ResultsReported its results
  2. May 22, 2026InsiderCEO sold ~$6.05M of ROIV shares in the open market
  3. Jun 24, 2026Insider · 1 personInsiders: 2 sales (~$6.6M)
  4. Jun 25, 2026 · this disclosureInsiderDirector sold ~$17.1M of ROIV shares in the open market

What came next

  1. Jun 26, 2026Insider · 4 peopleInsiders: 7 sales (~$80.9M)
  2. Jun 29, 2026Insider · 4 peopleInsiders: 8 sales (~$83.5M)
  3. Jun 30, 2026Insider · 4 peopleInsiders: 5 sales (~$8.7M)
  4. Jul 27, 2026InsiderCEO sold ~$6.99M of ROIV shares in the open market
  5. Aug 6, 2026Company filing · Form 8-K · ResultsReported its results
  6. Aug 14, 2026InsiderDirector sold ~$8.81M of ROIV shares in the open market
  7. Aug 17, 2026InsiderDirector sold ~$10.3M of ROIV shares in the open market
  8. Aug 18, 2026Insider · 1 personInsiders: 2 sales (~$5.0M)
  9. Aug 19, 2026InsiderDirector sold ~$6.43M of ROIV shares in the open market
  10. Aug 20, 2026InsiderDirector sold ~$653K of ROIV shares in the open market
  11. Aug 21, 2026InsiderDirector sold ~$5.28M of ROIV shares in the open market
  12. Aug 28, 2026Insider · 1 personInsiders: 2 sales (~$7.2M)
  13. Sep 8, 2026InsiderDirector sold ~$798K of ROIV shares in the open market
  14. Sep 15, 2026Insider · 2 peopleInsiders: 4 sales (~$399K)
  15. Sep 30, 2026InsiderCEO sold ~$7.32M of ROIV shares in the open market
  16. Oct 1, 2026Insider · 1 personInsiders: 2 sales (~$641K)
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Roivant Sciences

For Roivant Sciences, OQRO holds 18 insider filings (SEC Form 4 or Form 144) and 10 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its ROIV page.

Other recent filings by Mayukh Sukhatme, President & CIO

The full history of Mayukh Sukhatme, President & CIO is on the profile page.

How this filing works

Other disclosures at Roivant Sciences

Everything OQRO holds on this company is on its ROIV page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO ProAlready have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data